Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).

Publication

Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).

Journal Paper/Review - Apr 26, 2024

Couchepin Jade, Reinhold Ilana, Kronig Ilona, Guidi Monia, Buclin Thierry, Schreiber Peter W, Neofytos Dionysios, Lamoth Frédéric, Fungal Infection Network of Switzerland (FUNGINOS)

Citation

Couchepin J, Reinhold I, Kronig I, Guidi M, Buclin T, Schreiber P, Neofytos D, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS). Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS). Open Forum Infect Dis 2024; 11:ofae223.

Type

Journal Paper/Review (English)

Journal

Open Forum Infect Dis 2024; 11

Publication Date

Apr 26, 2024

Issn Print

2328-8957

Pages

ofae223

Brief description/objective

This analysis of 116 isavuconazole therapy courses shows that hepatic test disturbances (HTDs) were relatively frequent (29% of cases) but rarely led to treatment interruption (5%). Importantly, patients with baseline HTDs, including those attributed to a first-line triazole, did not exhibit a higher risk of subsequent HTD under isavuconazole therapy.